| 000 | 01738 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516064737.0 | ||
| 264 | 0 | _c20120525 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.05829-11 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoskowitz, Samuel M | |
| 245 | 0 | 0 |
_aPmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cFeb 2012 |
||
| 300 |
_a1019-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aColistin _xpharmacology |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation, Bacterial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPolymyxins _xpharmacology |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 700 | 1 | _aBrannon, Mark K | |
| 700 | 1 | _aDasgupta, Nandini | |
| 700 | 1 | _aPier, Miyuki | |
| 700 | 1 | _aSgambati, Nicole | |
| 700 | 1 | _aMiller, Amanda K | |
| 700 | 1 | _aSelgrade, Sara E | |
| 700 | 1 | _aMiller, Samuel I | |
| 700 | 1 | _aDenton, Miles | |
| 700 | 1 | _aConway, Steven P | |
| 700 | 1 | _aJohansen, Helle K | |
| 700 | 1 | _aHøiby, Niels | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 56 _gno. 2 _gp. 1019-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.05829-11 _zAvailable from publisher's website |
| 999 |
_c21333058 _d21333058 |
||